In this #TWiS post, I describe in details the recent efficacy story of the Bharat Biotech and Indian Council of Medical Research – National Institute of Virology COVAXIN based on their recent The Lancet Infectious Diseases paper. This blog summarises the findings of phase 1, 2 trials and the interim analysis of phase 3 trial. Proud to have received the two doses of CAVIXN at AIIMS, New Delhi.
More power to indigenous vaccines working towards Atmanirbhar Bharat.